A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Daniel J Gough Muhammad Alamgeer |
| Publication date | December 26, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |